Variant report

Variant	esv3397881
Chromosome Location	chr19:40150495-40199437
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:929)
CpG islands
(count:612)
Chromatin interactive
region (count:21)
LncRNA
region (count:10)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:929 , 50 per page) page: 1 2 3 4 5 6 7 ... 19

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr19:40186329-40186749	HepG2	liver:	n/a	n/a
2	ATF2	chr19:40169348-40171215	GM12878	blood:	n/a	n/a
3	ATF2	chr19:40191755-40192297	GM12878	blood:	n/a	n/a
4	ATF2	chr19:40194765-40195855	GM12878	blood:	n/a	n/a
5	ATF2	chr19:40182800-40183815	GM12878	blood:	n/a	n/a
6	ATF2	chr19:40166517-40167044	GM12878	blood:	n/a	n/a
7	ATF2	chr19:40166454-40167085	GM12878	blood:	n/a	n/a
8	ATF2	chr19:40169169-40171721	GM12878	blood:	n/a	n/a
9	ATF2	chr19:40196400-40196987	GM12878	blood:	n/a	n/a
10	ATF2	chr19:40182851-40183369	GM12878	blood:	n/a	n/a
11	ATF2	chr19:40191735-40192471	GM12878	blood:	n/a	n/a
12	ATF2	chr19:40177332-40177734	GM12878	blood:	n/a	n/a
13	ATF2	chr19:40196409-40196856	GM12878	blood:	n/a	n/a
14	BACH1	chr19:40181595-40181848	H1-hESC	embryonic stem cell:	n/a	n/a
15	BATF	chr19:40166440-40167020	GM12878	blood:	n/a	n/a
16	BATF	chr19:40189256-40189554	GM12878	blood:	n/a	n/a
17	BATF	chr19:40169465-40170751	GM12878	blood:	n/a	n/a
18	BATF	chr19:40182871-40183555	GM12878	blood:	n/a	chr19:40183116-40183126
19	BATF	chr19:40164543-40164840	GM12878	blood:	n/a	n/a
20	BATF	chr19:40166542-40166952	GM12878	blood:	n/a	n/a
21	BATF	chr19:40189261-40189535	GM12878	blood:	n/a	n/a
22	BCL11A	chr19:40166534-40167022	GM12878	blood:	n/a	chr19:40166845-40166854
23	BCL11A	chr19:40169661-40170751	GM12878	blood:	n/a	n/a
24	BCL11A	chr19:40195179-40195439	GM12878	blood:	n/a	n/a
25	BCL11A	chr19:40199281-40199588	GM12878	blood:	n/a	chr19:40199450-40199459
26	BCL3	chr19:40182662-40183301	GM12878	blood:	n/a	chr19:40183115-40183124 chr19:40183114-40183123
27	BCL3	chr19:40169586-40170952	GM12878	blood:	n/a	chr19:40169623-40169631
28	BCL3	chr19:40191856-40192273	GM12878	blood:	n/a	n/a
29	BCL3	chr19:40195147-40195808	GM12878	blood:	n/a	n/a
30	BCL3	chr19:40182720-40183232	GM12878	blood:	n/a	chr19:40183115-40183124 chr19:40183114-40183123
31	BCL3	chr19:40177478-40177702	GM12878	blood:	n/a	chr19:40177575-40177584
32	BCL3	chr19:40166516-40167084	GM12878	blood:	n/a	chr19:40166845-40166854
33	BCL3	chr19:40196414-40196839	GM12878	blood:	n/a	chr19:40196768-40196777
34	BCL3	chr19:40170081-40170842	GM12878	blood:	n/a	n/a
35	BCL3	chr19:40166584-40167009	GM12878	blood:	n/a	chr19:40166845-40166854
36	BCLAF1	chr19:40169441-40171302	GM12878	blood:	n/a	chr19:40169623-40169631
37	BCLAF1	chr19:40191657-40192395	GM12878	blood:	n/a	n/a
38	BCLAF1	chr19:40199155-40199615	GM12878	blood:	n/a	chr19:40199450-40199459
39	BCLAF1	chr19:40196448-40196899	GM12878	blood:	n/a	chr19:40196768-40196777
40	BCLAF1	chr19:40169381-40171764	GM12878	blood:	n/a	chr19:40169623-40169631
41	BCLAF1	chr19:40194839-40195814	GM12878	blood:	n/a	n/a
42	BCLAF1	chr19:40166547-40167019	GM12878	blood:	n/a	chr19:40166845-40166854
43	BHLHE40	chr19:40196585-40196856	GM12878	blood:	n/a	n/a
44	BHLHE40	chr19:40191938-40192401	GM12878	blood:	n/a	n/a
45	BHLHE40	chr19:40169675-40171090	GM12878	blood:	n/a	n/a
46	BHLHE40	chr19:40195058-40195839	GM12878	blood:	n/a	n/a
47	BHLHE40	chr19:40183715-40183926	GM12878	blood:	n/a	n/a
48	BHLHE40	chr19:40186478-40186798	HepG2	liver:	n/a	n/a
49	BHLHE40	chr19:40171344-40171662	GM12878	blood:	n/a	n/a
50	BRCA1	chr19:40198082-40198120	Hela-S3	cervix:	n/a	n/a

(count:612 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:40195142-40195192	HPAEpiC	pulmonary alveolar:	n/a
2	chr19:40169912-40169962	HAEpiC	amniotic membrane:	n/a
3	chr19:40195142-40195192	HPAEpiC	pulmonary alveolar:	n/a
4	chr19:40169912-40169962	HAEpiC	amniotic membrane:	n/a
5	chr19:40169418-40169468	U87	brain:	n/a
6	chr19:40193890-40193940	MCF10A-Er-Src	breast:	n/a
7	chr19:40168876-40168926	AG04449	skin:	fetal
8	chr19:40195028-40195078	AG09319	gingival:	n/a
9	chr19:40168876-40168926	HRPEpiC	eye:	n/a
10	chr19:40195142-40195192	ovcar-3	ovarian:	n/a
11	chr19:40174352-40174402	ProgFib	skin:	n/a
12	chr19:40168558-40168608	GM12878	blood:	n/a
13	chr19:40168558-40168608	SK-N-SH	brain:	n/a
14	chr19:40168558-40168608	AG09309	skin:	n/a
15	chr19:40193890-40193940	ProgFib	skin:	n/a
16	chr19:40174352-40174402	GM12892	blood:	n/a
17	chr19:40193890-40193940	SK-N-MC	brain:	n/a
18	chr19:40174352-40174402	HIPEpiC	eye:	n/a
19	chr19:40169912-40169962	HL-60	blood:	n/a
20	chr19:40168876-40168926	NH-A	brain:	n/a
21	chr19:40169912-40169962	SK-N-SH	brain:	n/a
22	chr19:40195983-40196033	Jurkat	blood:	n/a
23	chr19:40169912-40169962	HRCEpiC	kidney:	n/a
24	chr19:40169839-40169889	HCM	heart:	n/a
25	chr19:40193890-40193940	ECC-1	luminal epithelium:	n/a
26	chr19:40169418-40169468	AG04450	lung:	fetal
27	chr19:40169839-40169889	ovcar-3	ovarian:	n/a
28	chr19:40193890-40193940	AG04450	lung:	fetal
29	chr19:40169912-40169962	H1-hESC	embryonic stem cell:	embryo
30	chr19:40169839-40169889	Hepatocyte	liver:	n/a
31	chr19:40169418-40169468	Caco-2	colon:	n/a
32	chr19:40169418-40169468	PANC-1	pancreas:	n/a
33	chr19:40169839-40169889	HPAEpiC	pulmonary alveolar:	n/a
34	chr19:40169912-40169962	HNPCEpiC	eye:	n/a
35	chr19:40169418-40169468	T-47D	breast:	n/a
36	chr19:40169912-40169962	PrEC	prostate:	n/a
37	chr19:40169418-40169468	Hepatocyte	liver:	n/a
38	chr19:40195983-40196033	SK-N-MC	brain:	n/a
39	chr19:40174352-40174402	MCF-7	breast:	n/a
40	chr19:40195142-40195192	HRPEpiC	eye:	n/a
41	chr19:40193890-40193940	GM19239	blood:	n/a
42	chr19:40195142-40195192	HNPCEpiC	eye:	n/a
43	chr19:40195983-40196033	HCT-116	colon:	n/a
44	chr19:40169418-40169468	NH-A	brain:	n/a
45	chr19:40195028-40195078	GM12892	blood:	n/a
46	chr19:40174352-40174402	NH-A	brain:	n/a
47	chr19:40193890-40193940	HCF	heart:	n/a
48	chr19:40193890-40193940	NH-A	brain:	n/a
49	chr19:40169418-40169468	AG09309	skin:	n/a
50	chr19:40168558-40168608	AG09319	gingival:	n/a

(count:21 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr19:40191402..40192980-chr19:40193546..40196170,2	K562	blood:
2	chr19:40041783..40042891-chr19:40162333..40163330,4	K562	blood:
3	chr19:40164310..40165291-chr19:40476366..40477083,2	MCF-7	breast:
4	chr19:40166471..40169299-chr19:40170755..40172585,2	K562	blood:
5	chr19:40095220..40098051-chr19:40194257..40195861,2	K562	blood:
6	chr19:40163210..40165073-chr19:40333318..40334922,2	MCF-7	breast:
7	chr19:39988438..39989161-chr19:40162366..40162932,2	K562	blood:
8	chr19:39925057..39927468-chr19:40150682..40153479,2	K562	blood:
9	chr19:40187755..40190590-chr19:40198556..40200389,2	MCF-7	breast:
10	chr19:40168776..40170659-chr19:40171070..40173926,2	MCF-7	breast:
11	chr19:40166260..40168931-chr19:40253973..40255544,2	MCF-7	breast:
12	chr19:40172219..40174410-chr19:40181019..40183380,2	MCF-7	breast:
13	chr19:40168776..40170659-chr19:40171070..40173926,2	MCF-7	breast:
14	chr19:40164188..40165085-chr19:40256246..40256847,2	MCF-7	breast:
15	chr19:40041798..40042719-chr19:40162291..40163385,9	MCF-7	breast:
16	chr12:31226694..31227233-chr19:40172228..40172728,2	HCT-116	colon:
17	chr19:40163659..40164641-chr19:40256992..40257878,2	MCF-7	breast:
18	chr19:40172219..40174410-chr19:40181019..40183380,2	MCF-7	breast:
19	chr19:40164964..40166897-chr19:40168193..40170501,2	K562	blood:
20	chr19:40041871..40042653-chr19:40162390..40162892,2	MCF-7	breast:
21	chr19:39988198..39988763-chr19:40162454..40163227,2	MCF-7	breast:

(count:10 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-LGALS14-1	chr19:40174127-40174403	NR_034156
2	lnc-LGALS14-1	chr19:40172638-40172848	NR_034156
3	lnc-LGALS14-1	chr19:40170014-40170074	NR_034156
4	lnc-LGALS14-1	chr19:40185104-40185217	ENSG00000226025
5	lnc-LGALS14-1	chr19:40172073-40172149	NR_034156
6	lnc-LGALS14-1	chr19:40176193-40176292	NR_034156
7	lnc-LGALS14-1	chr19:40175350-40175447	NR_034156
8	lnc-LGALS14-1	chr19:40175942-40176058	NR_034156
9	lnc-LGALS14-1	chr19:40175884-40176058	ENSG00000226025
10	lnc-LGALS14-1	chr19:40176825-40177013	NR_034156

No data

Variant related genes	Relation type
ENSG00000268088	TF binding region
ENSG00000269460	TF binding region
LGALS14	TF binding region
ENSG00000226025	TF binding region
ENSG00000240320	TF binding region
ENSG00000268088	CpG island
ENSG00000269460	CpG island
LGALS14	CpG island
ENSG00000226025	CpG island
ENSG00000240320	CpG island
ENSG00000006659	chromatin interactions
ENSG00000226025	chromatin interactions
ENSG00000240320	chromatin interactions
ENSG00000105198	chromatin interactions
ENSG00000105193	chromatin interactions
ENSG00000013275	chromatin interactions
ENSG00000013573	chromatin interactions
ENSG00000196235	chromatin interactions
ENSG00000245614	chromatin interactions

Extended variants
information (count: 1729 )
Associated
traits (count: 67 )

Variant overlapped rSNPs/rCNVs (count:1729 , 50 per page) page: 1 2 3 4 5 6 7 ... 35

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs545858940	chr19:40150505-40150506	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs144704811	chr19:40150510-40150511	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs550498674	chr19:40150539-40150540	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs117566288	chr19:40150554-40150555	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs532845841	chr19:40150561-40150562	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs547404281	chr19:40150563-40150564	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs34447854	chr19:40150659-40150660	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs565519450	chr19:40150675-40150676	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs536370206	chr19:40150682-40150683	Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs115109505	chr19:40150688-40150689	Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs116730260	chr19:40150689-40150690	Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs558318056	chr19:40150700-40150701	Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs185363490	chr19:40150715-40150716	Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs114379296	chr19:40150830-40150831	Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs562776723	chr19:40150832-40150833	Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs199762854	chr19:40150833-40150834	Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs77574137	chr19:40150886-40150887	Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs138521968	chr19:40150897-40150898	Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs572313928	chr19:40150918-40150919	Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs543116173	chr19:40150983-40150984	Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs561317858	chr19:40150999-40151000	Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs535001596	chr19:40151001-40151002	Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs576608172	chr19:40151016-40151017	Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs544070747	chr19:40151034-40151035	Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs190910422	chr19:40151047-40151048	Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs532870150	chr19:40151057-40151058	Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs547747297	chr19:40151072-40151073	Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs559317635	chr19:40151081-40151082	Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs181925874	chr19:40151098-40151099	Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs548886655	chr19:40151121-40151122	Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs148828240	chr19:40151124-40151125	Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs186797209	chr19:40151145-40151146	Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs367627881	chr19:40151153-40151154	Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs536730057	chr19:40151168-40151169	Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs191782299	chr19:40151171-40151172	Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs112620313	chr19:40151214-40151215	Inactive region	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs183190594	chr19:40151271-40151272	Inactive region	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs534932394	chr19:40151315-40151316	Inactive region	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs533236353	chr19:40151317-40151318	Inactive region	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs552950120	chr19:40151352-40151353	Inactive region	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs186501971	chr19:40151401-40151402	Inactive region	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs536296421	chr19:40151413-40151414	Inactive region	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs551620297	chr19:40151420-40151421	Inactive region	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs190177577	chr19:40151438-40151439	Inactive region	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs7258599	chr19:40151473-40151474	Inactive region	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs993983	chr19:40151480-40151481	Inactive region	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
47	rs182111812	chr19:40151483-40151484	Inactive region	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs186667026	chr19:40151502-40151503	Inactive region	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs192340466	chr19:40151513-40151514	Inactive region	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs541722606	chr19:40151531-40151532	Inactive region	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:67)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Pleomorphic liposarcoma	18784837	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Disorders of sex development	21048976	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Invasive pancreatic ductal carcinoma	18765526	CNVD
Rhabdomyosarcoma	16790082	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Wilms tumour	21544195	CNVD
Mental retardation	19951919	CNVD
19q13.11 deletion syndrome	22378287	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	21045282	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Ovarian neoplasms	16753589	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Lung cancer	21569311	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Gastric cancer	18160780	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	19029149	CNVD
Breast cancer	20409316	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Multiple myeloma	16616336	CNVD
Renal cell carcinoma	18765545	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:283 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:40133200-40151200	Weak transcription	Placenta	Placenta
2	chr19:40150600-40151200	Bivalent Enhancer	GM12878-XiMat	blood
3	chr19:40152200-40153000	Enhancers	Primary T cells from cord blood	blood
4	chr19:40161200-40162600	Enhancers	H9 Cell Line	embryonic stem cell
5	chr19:40161200-40162600	Enhancers	HUES64 Cell Line	embryonic stem cell
6	chr19:40161200-40162600	Enhancers	iPS-20b Cell Line	embryonic stem cell
7	chr19:40161200-40162600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
8	chr19:40161200-40162800	Enhancers	ES-I3 Cell Line	embryonic stem cell
9	chr19:40161200-40162800	Enhancers	HUES48 Cell Line	embryonic stem cell
10	chr19:40161200-40162800	Enhancers	HUES6 Cell Line	embryonic stem cell
11	chr19:40161200-40162800	Enhancers	iPS-15b Cell Line	embryonic stem cell
12	chr19:40161400-40162600	Enhancers	H1 Cell Line	embryonic stem cell
13	chr19:40161400-40162800	Enhancers	iPS-18 Cell Line	embryonic stem cell
14	chr19:40161800-40162000	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
15	chr19:40162400-40162600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
16	chr19:40162400-40162600	Bivalent Enhancer	Primary T killer memory cells from peripheral blood	blood
17	chr19:40162400-40162600	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
18	chr19:40162400-40162600	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
19	chr19:40162400-40162600	Enhancers	Brain Hippocampus Middle	brain
20	chr19:40162400-40162800	Enhancers	Pancreatic Islets	Pancreatic Islet
21	chr19:40162400-40163200	Enhancers	Skeletal Muscle Female	skeletal muscle
22	chr19:40162400-40163200	Enhancers	GM12878-XiMat	blood
23	chr19:40162400-40164600	Enhancers	Primary T helper naive cells from peripheral blood	blood
24	chr19:40162400-40164600	Enhancers	Primary T helper cells PMA-I stimulated	--
25	chr19:40162600-40162800	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
26	chr19:40162600-40162800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
27	chr19:40162600-40163600	Enhancers	Primary T killer naive cells fromperipheralblood	blood
28	chr19:40162600-40164200	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
29	chr19:40162600-40164600	Enhancers	Primary T helper naive cells fromperipheralblood	blood
30	chr19:40162600-40164600	Enhancers	Primary T killer memory cells from peripheral blood	blood
31	chr19:40162600-40169600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
32	chr19:40162800-40163000	Enhancers	Skeletal Muscle Male	skeletal muscle
33	chr19:40162800-40163000	Bivalent Enhancer	A549	lung
34	chr19:40162800-40163800	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
35	chr19:40162800-40164200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
36	chr19:40162800-40164400	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
37	chr19:40162800-40164600	Enhancers	Primary T helper cells fromperipheralblood	blood
38	chr19:40162800-40166800	Weak transcription	ES-I3 Cell Line	embryonic stem cell
39	chr19:40163000-40164200	Enhancers	Primary T cells fromperipheralblood	blood
40	chr19:40163200-40163400	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
41	chr19:40163200-40164200	Weak transcription	GM12878-XiMat	blood
42	chr19:40163200-40168200	Weak transcription	Skeletal Muscle Female	skeletal muscle
43	chr19:40163400-40164200	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
44	chr19:40163800-40164400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
45	chr19:40164200-40164400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
46	chr19:40164200-40164400	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
47	chr19:40164200-40166200	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
48	chr19:40164200-40168600	Weak transcription	Primary T cells fromperipheralblood	blood
49	chr19:40164200-40168600	Weak transcription	Primary T helper memory cells from peripheral blood 2	blood
50	chr19:40164200-40168600	Enhancers	GM12878-XiMat	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links